Measuring depressive symptoms in the naturalistic primary-care setting

International Journal of Clinical Practice

Volumn 61, Issue 8, 2007, Pages 1278-1282

  McIntyre, R S ^a,b,c   Konarski, J Z ^b   Kennedy, S H ^a,b,c   Dickens, S E ^d   Bagby, R M ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FATIGUE; FEMALE; GUILT; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MONOTHERAPY; MOOD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; SCORING SYSTEM; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34447324608     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01448.x     Document Type: Article

References (23)

1. Von Korff M, Katon W, Unutzer J et al. Improving depression care: barriers, solutions, and research needs. J Fam Pract 2001 50 : E1.
2. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998 155 : 4 11.
3. Kessler RC, Berglund P, Demler O et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003 289 : 3095 105.
4. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 2003 289 : 3152 60.
5. Bech P, Gram LF, Dein E et al. Quantitative rating of depressive states. Acta Psychiatr Scand 1975 51 : 161 70.
6. Maier W, Philipp M. Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Rating Scale. Pharmacopsychiatry 1985 18 : 114 5.
7. Gibbons RD, Clark DC, Kupfer DJ. Exactly what does the Hamilton Depression Rating Scale measure J Psychiatr Res 1993 27 : 259 73.
8. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999 282 : 1737 44.
9. Zimmerman M, Posternak MA, Chelminski I. Using a self-report depression scale to identify remission in depressed outpatients. Am J Psychiatry 2004 161 : 1911 13.
10. McIntyre RS, Konarski JZ, Mancini DA et al. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ 2005 173 : 1327 34.
11. Steer RA, Cavalieri TA, Leonard DM et al. Use of the beck depression inventory for primary care to screen for major depression disorders. Gen Hosp Psychiatry 1999 21 : 106 11.
12. Enns MW, Larsen DK, Cox BJ. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affect Disord 2000 60 : 33 41.
13. McIntyre R, Kennedy S, Bagby RM et al. Assessing full remission. J Psychiatry Neurosci 2002 27 : 235 9.
14. Bagby RM, Ryder AG, Schuller DR et al. The hamilton depression rating scale: has the gold standard become a lead weight Am J Psychiatry 2004 161 : 2163 77.
15. Guy W. ECDEU Assessment Manual for Psychopharmacology, 2nd edn. Washington DC : US Government Printing Office, 1976.
16. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 : 382 9.
17. Frank E, Prien RF, Jarrett RB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991 48 : 851 55.
18. Zimmerman M, Posternak MA, Chelminski I. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 2004 38 : 577 82.
19. Faries D, Herrera J, Rayamajhi J et al. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 2000 34 : 3 10.
20. Rush AJ, Trivedi MH, Ibrahim HM et al. Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003 54 : 573 83.
21. Zimmerman M, McGlinchey JB, Posternak MA et al. Differences between minimally depressed patients who do and do not consider themselves to be in remission. J Clin Psychiatry 2005 66 : 1134 8.
22. Nierenberg AA, Keefe BR, Leslie VC et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999 60 : 221 25.
23. Thase ME, Sloan DM, Kornstein SG. Remission as the critical outcome of depression treatment. Psychopharmacol Bull 2002 36 : 12 25.